{"id":"W4401281322","doi":"10.1016/j.lungcan.2024.107919","title":"Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Pfizer (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute; EMD Serono; International Society for Pharmacoepidemiology; Gilead Sciences; Sanofi; Genentech; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Anaplastic lymphoma kinase; ALK inhibitor; Lung cancer; Tyrosine kinase; Tyrosine-kinase inhibitor; Cancer research; Ceritinib; Oncology; Internal medicine; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001094504,0.0002694381,0.000415956,0.0001568759,0.0001285602,0.00004233321,0.00002552466,0.00007669001,0.00003264681],"category_scores_gemma":[0.000005905953,0.0002136152,0.00008979639,0.0002227463,0.00005713417,0.0001656424,0.00001963584,0.00008474037,2.946124e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002100112,"about_ca_system_score_gemma":0.0007532066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005282122,"about_ca_topic_score_gemma":0.005854609,"domain_scores_codex":[0.9988359,0.00004028781,0.0002558837,0.0005010685,0.0001188482,0.0002480236],"domain_scores_gemma":[0.9992997,0.0001801057,0.00009094273,0.0001539455,0.0001483319,0.0001269832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009280513,0.0001882197,0.05853736,0.009327388,0.002075377,0.00008076459,0.00769763,0.001799523,0.8895034,0.0005846127,0.001476104,0.02780156],"study_design_scores_gemma":[0.008726851,0.001111027,0.04826807,0.005252812,0.004600759,0.00001279679,0.0002930829,0.02730039,0.9017388,0.0000520309,0.002148786,0.0004945641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9627658,0.03121861,0.0004183728,0.0002343944,0.0007152627,0.002549869,0.000550588,0.00005538755,0.001491748],"genre_scores_gemma":[0.9909567,0.002975801,0.0007743773,0.00008096417,0.0003808226,0.001869056,0.0001753259,0.00005704203,0.002729899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02824281,"threshold_uncertainty_score":0.8710975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01174501105919376,"score_gpt":0.329370564327469,"score_spread":0.3176255532682752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}